{"id":"sc-tulisokibart","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"As an investigational agent in Phase 3 development by Merck Sharp & Dohme, tulisokibart appears to function as an immunomodulatory therapy. The subcutaneous formulation suggests optimization for patient convenience and tolerability in chronic or repeated dosing scenarios, though the specific molecular target and detailed mechanism of action are not publicly well-characterized.","oneSentence":"SC Tulisokibart is a subcutaneous immunotherapy agent designed to modulate immune responses, though its precise molecular mechanism requires further clarification.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:33:44.197Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07133633","phase":"PHASE2","title":"A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-09-26","conditions":"Radiographic Axial Spondyloarthritis","enrollment":315},{"nctId":"NCT06430801","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-05","conditions":"Crohn's Disease","enrollment":1200},{"nctId":"NCT06052059","phase":"PHASE3","title":"A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-10-25","conditions":"Ulcerative Colitis","enrollment":1020},{"nctId":"NCT07176390","phase":"PHASE2","title":"A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-10-08","conditions":"Arthritis, Rheumatoid","enrollment":182},{"nctId":"NCT06956235","phase":"PHASE2","title":"Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-06-09","conditions":"Hidradenitis Suppurativa","enrollment":147},{"nctId":"NCT06651281","phase":"PHASE3","title":"Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-11-25","conditions":"Crohn Disease, Colitis, Ulcerative","enrollment":1380},{"nctId":"NCT06575595","phase":"PHASE1","title":"Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-09-24","conditions":"Healthy","enrollment":60},{"nctId":"NCT06829225","phase":"PHASE1","title":"Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-13","conditions":"Colitis, Ulcerative","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["PRA023","MK-7240"],"phase":"phase_3","status":"active","brandName":"SC Tulisokibart","genericName":"SC Tulisokibart","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}